Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Buy
4,214
+1,216
+41% +$117K ﹤0.01% 1952
2025
Q4
$278K Sell
2,998
-11,975
-80% -$1.3M ﹤0.01% 2072
2025
Q3
$1.87M Sell
14,973
-873
-6% -$111K 0.01% 946
2025
Q2
$2.09M Buy
15,846
+10,363
+189% +$1.17M 0.01% 827
2025
Q1
$574K Sell
5,483
-5,929
-52% -$621K ﹤0.01% 1439
2024
Q4
$1.23M Sell
11,412
-2,450
-18% -$274K 0.01% 1136
2024
Q3
$1.65M Buy
13,862
+11,363
+455% +$1.15M 0.01% 981
2024
Q2
$239K Buy
+2,499
New +$251K ﹤0.01% 2072

Other funds holding ITRI

Sanctuary Advisors's ITRI Position: Q1 2026 in Review

Sanctuary Advisors increased its Itron (ITRI) stake by 41% in Q1 2026, buying an estimated $117K and bringing the position to 4,214 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Sanctuary Advisors first reported a position in ITRI in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.09M in Q2 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Sanctuary Advisors held 4,214 shares of Itron worth $378K as of Q1 2026.
  • Sanctuary Advisors bought 1,216 Itron shares in Q1 2026, an estimated $117K.
  • Itron made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #1952 holding.
  • Sanctuary Advisors first reported a position in Itron in Q2 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Itron position peaked at $2.09M in Q2 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.